Eventide Asset Management, Llc Buys Zogenix Inc, Sarepta Therapeutics Inc, Exact Sciences Corp, Sells bluebird bio Inc, Altair Engineering Inc, Intercept Pharmaceuticals Inc

• New Purchases: SERV, IDXX, MRTX, IAA, KRTX, PS, STRO, ISRG, ORTX, SVRA, NEE, WM, HCP, EQR,
• Added Positions: ZGNX, SRPT, EXAS, STML, XYL, WCN, MTD, AIMT, MYOV, PANW, BHVN, GWPH, KALV, ROP, TLND, RARX, CRNX, FIVN, MYOK, GBT, NBIX, MGTA, VMC, XENE, RGEN, FOLD, RCKT, XNCR, COLL, CCI, EPIX, IR, LOW, ERIC, ARE, PLD, PEGI, APTV, NEP, NOK, BEP,
• Reduced Positions: BLUE, QURE, XPO, MNTA, IMMU, SAGE, KNSA, UROV, ADVM, ABB, MGA, MIC, TSM, JCI, TERP, ETN, MLHR,
• Sold Out: ALTR, ICPT, WBC, VKTX, IFRX, ARQL, SNSS, WVE, XLRN, VRTX, VBIV, CERC, HMC, BDN, CCIPA.PFD, GPMT, CVA, LXP, PSA, CIG, NXPI, WDC, VTR, CWEN,

For the details of EVENTIDE ASSET MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/eventide+asset+management%2C+llc/current-portfolio/portfolio

1. Ascendis Pharma A/S (ASND) - 1,698,648 shares, 5.99% of the total portfolio.
2. Sarepta Therapeutics Inc (SRPT) - 1,123,000 shares, 5.22% of the total portfolio. Shares added by 32.87%
3. Sage Therapeutics Inc (SAGE) - 755,000 shares, 4.23% of the total portfolio. Shares reduced by 6.21%
4. Zogenix Inc (ZGNX) - 2,841,300 shares, 4.15% of the total portfolio. Shares added by 49.94%
5. Twilio Inc (TWLO) - 827,000 shares, 3.45% of the total portfolio.

Eventide Asset Management, Llc initiated holding in ServiceMaster Global Holdings Inc. The purchase prices were between $46.9 and $54.52, with an estimated average price of $51.45. The stock is now traded at around $58.36. The impact to a portfolio due to this purchase was 1.11%. The holding were 698,000 shares as of .

Eventide Asset Management, Llc initiated holding in IDEXX Laboratories Inc. The purchase prices were between $215.53 and $275.33, with an estimated average price of $246.11. The stock is now traded at around $282.30. The impact to a portfolio due to this purchase was 0.87%. The holding were 102,900 shares as of .

Eventide Asset Management, Llc initiated holding in Mirati Therapeutics Inc. The purchase prices were between $59.49 and $104.71, with an estimated average price of $77.61. The stock is now traded at around $88.63. The impact to a portfolio due to this purchase was 0.77%. The holding were 243,000 shares as of .

Eventide Asset Management, Llc initiated holding in IAA Inc. The purchase prices were between $36.57 and $40, with an estimated average price of $38.68. The stock is now traded at around $46.53. The impact to a portfolio due to this purchase was 0.72%. The holding were 610,000 shares as of .

Eventide Asset Management, Llc initiated holding in Karuna Therapeutics Inc. The purchase prices were between $20.02 and $20.02, with an estimated average price of $20.02. The stock is now traded at around $21.74. The impact to a portfolio due to this purchase was 0.68%. The holding were 1,136,234 shares as of .

Eventide Asset Management, Llc initiated holding in Pluralsight Inc. The purchase prices were between $29.07 and $35.49, with an estimated average price of $32.12. The stock is now traded at around $15.78. The impact to a portfolio due to this purchase was 0.6%. The holding were 645,000 shares as of .

Eventide Asset Management, Llc added to a holding in Zogenix Inc by 49.94%. The purchase prices were between $36.17 and $54.96, with an estimated average price of $40.18. The stock is now traded at around $50.38. The impact to a portfolio due to this purchase was 1.38%. The holding were 2,841,300 shares as of .

Eventide Asset Management, Llc added to a holding in Sarepta Therapeutics Inc by 32.87%. The purchase prices were between $112.21 and $151.95, with an estimated average price of $121.45. The stock is now traded at around $99.56. The impact to a portfolio due to this purchase was 1.29%. The holding were 1,123,000 shares as of .

Eventide Asset Management, Llc added to a holding in Exact Sciences Corp by 253.57%. The purchase prices were between $89.51 and $118.04, with an estimated average price of $100.57. The stock is now traded at around $120.05. The impact to a portfolio due to this purchase was 1.28%. The holding were 495,000 shares as of .

Eventide Asset Management, Llc added to a holding in Stemline Therapeutics Inc by 98.36%. The purchase prices were between $12.9 and $16.1, with an estimated average price of $14.45. The stock is now traded at around $14.94. The impact to a portfolio due to this purchase was 0.74%. The holding were 3,192,727 shares as of .

Eventide Asset Management, Llc added to a holding in Xylem Inc by 72.02%. The purchase prices were between $73.93 and $83.82, with an estimated average price of $79.64. The stock is now traded at around $76.07. The impact to a portfolio due to this purchase was 0.73%. The holding were 682,900 shares as of .

Eventide Asset Management, Llc added to a holding in Waste Connections Inc by 33.55%. The purchase prices were between $87.3 and $95.73, with an estimated average price of $92.14. The stock is now traded at around $92.35. The impact to a portfolio due to this purchase was 0.59%. The holding were 804,000 shares as of .

Eventide Asset Management, Llc sold out a holding in Altair Engineering Inc. The sale prices were between $34.05 and $40.39, with an estimated average price of $37.38.

Eventide Asset Management, Llc sold out a holding in Intercept Pharmaceuticals Inc. The sale prices were between $77.77 and $120.68, with an estimated average price of $89.45.

Eventide Asset Management, Llc sold out a holding in WABCO Holdings Inc. The sale prices were between $130.26 and $133.6, with an estimated average price of $131.9.

Eventide Asset Management, Llc sold out a holding in Viking Therapeutics Inc. The sale prices were between $7.67 and $10.63, with an estimated average price of $8.55.

Eventide Asset Management, Llc sold out a holding in InflaRx NV. The sale prices were between $3.06 and $51.61, with an estimated average price of $31.98.

Eventide Asset Management, Llc sold out a holding in Arqule Inc. The sale prices were between $4.77 and $11.01, with an estimated average price of $6.96.